MeSH Browser

MeSH Supplementary: etrolizumab
Unique ID: C559198
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C559198
Entry Term(s): ANTI-.BETA.7; ANTI-BETA7; PRO-145223; PRO145223; RHUMAB .BETA.7; rhuMAb Beta7
Pharm Action: Gastrointestinal Agents
Immunologic Factors
Registry Number: I2A72G2V3J
Previous Indexing: *ANTIBODIES, MONOCLONAL (2011-2014)
Heading Mapped to: *Antibodies, Monoclonal, Humanized
Frequency: 42
Note: selectively blocks lymphocyte homing to the gastrointestinal tract without affecting lymphocyte trafficking to non-mucosal tissues
Source: Br J Pharmacol. 2011 Apr;162(8):1855-70
Date of Entry: 2011/07/07
Revision Date: 2019/10/31

Concept UI: M0558879
Terms: rhuMAb Beta7 Preferred Term
Term UI T793127
Date07/07/2011
LexicalTag NON
ThesaurusID NLM (2011); ANTI-BETA7
Term UI T000967587
Date09/06/2019
LexicalTag NON
ThesaurusID NLM (2020); ANTI-.BETA.7
Term UI T000967585
Date09/06/2019
LexicalTag NON
ThesaurusID NLM (2020); RHUMAB .BETA.7
Term UI T000967586
Date09/06/2019
LexicalTag NON
ThesaurusID NLM (2020)

etrolizumab MeSH Supplementary Concept Data 2023